Epilepsy and Variables. Department of Neurology, Hospital de Clínicas from 2016 to 2018
DOI:
https://doi.org/10.18004/anales/2019.052.03.47-052Keywords:
Epilepsy, Population at risk, Antiepileptic drugs, ParaguayAbstract
In the world there are about 50 million people with epilepsy. In low and middle income countries they suggest a much higher proportion, between 7 and 14 per 1000 people. Poor populations and those living in vulnerable situations, particularly in low and middle income countries, carry a disproportionately high burden; which poses a threat to public health and economic and social development. 1 Whereby the purpose of the study was to know the epidemiological characteristic of this population. Were analyzed 281 records of patients with epilepsy, over a period of two years, between 16 and 91 years. Results: 51.9% correspond to the male sex and 48.1% to the female. 63.34% presented focal crisis. 59.2 of epilepsy cases are accompanied by psychiatric disorders. Only 5% have claimed to have suffered any adverse effect to the medication. The cause of epilepsy in 58.58% is unknown. Within the causes of secondary epilepsy; Stroke is 22.4%. Notably, the 30.2% of patients do not have a brain imaging study; 41.93% presented a crisis with treatment, but 50% of patients performed irregular treatment. 53.73% had treatment with a single anticonvulsant drug, with Carbamazepine being the most used. Conclusion: Epilepsy has a high prevalence within neurological disorders. It affects the male sex more importantly, with the focal crisis being the most frequent. The low association with psychiatric disorders found; it forces us to emphasize being more exhaustive in the search for these. The cause is unknown in a high percentage. The most frequent causes of secondary epilepsy were CVA and Skull Trauma. A considerable percentage continue with crisis due to non-compliance with treatment. Carbamazepine, Valproic Acid and Phenytoin are the most used, due to their costs and accessibility, efforts should be established to propose intervention strategies, to facilitate the monitoring of patients and so that they can also benefit from new anticonvulsant drugs.
References
1. Megiddo I, Colson A, Chisholm D, Dua T, Nandi A, and Laxminarayan R (2106). Health and economic benefits of public financing of epilepsy treatment in India: An agent-based simulation model. Epilepsia Official Journal of the International League Against Epilepsy. Disponible en: http://www.who.int/es/news-room/fact-sheets/detail/epilepsy
2. Grauss-Tejeda, Juan M; Huerto-Aguilar, Jos‚ L; Macavilca-Cruz, Marco A; Nájar-Trujillo, Néstor E; Rodr¡guez-Hurtado, Diana. Factores clínicos y epidemiológicos relacionados a mortalidad en pacientes con estatus epiléptico en un hospital de Lima: una serie comparativa de casos / Clinical and epidemiological factors related with mortality in patients with status epilepticus in a general hospital in Lima: a comparative case series. Rev. neuropsiquiatr;79(4):207-215, oct.-dic. 2016
3. De la Cruz, Walter F; Zapata, Willy R; Delgado, José C; Mija, Lizardo. Estado epiléptico convulsivo en adultos atendidos en el Instituto Nacional de Ciencias Neurológicas de Lima, Perú 2011-2013. / Convulsive status epilepticus in adults attending the Instituto Nacional de Ciencias Neurológicas in Lima, Perú 2011-2013. Rev. neuropsiquiatr;77(4):236-241, oct. 2014
4. Nascimento Pedro Paulo Gomes do, Oliva Carlos Henrique, Franco Clelia Maria Ribeiro, Mazetto Lennon, Yamashiro Alberto S., Araujo Filho Gerardo Maria de et al. Interictal dysphoric disorder: a frequent psychiatric comorbidity among patients with epilepsy who were followed in two tertiary centers. Arq. Neuro-Psiquiatr. 2013 Nov ; 71( 11 ): 852-855. Disponible en: http://www.scielo.br/scielo.php.script
5. Valente Kette Dualibi Ramos, Thomé-Souza Sigride, Kuczynski Evelyn, Negrão Núbio. Depressão em crianças e adolescentes com epilepsia. Rev. psiquiatr. clín. [Internet]. 2004; 31( 6 ): 290-299.
6. Wigg Cristina, Maria Duarte, Filgueiras Alberto, Gomes Marleide da Mota. The relationship between sleep quality, depression, and anxiety in patients with epilepsy and suicidal ideation. Arq. Neuro-Psiquiatr. 2014 May ;72( 5 ): 344-348.
7. Stefanello S, Marín-Léon L, Fernandes P T, Li L M, Botega N J. Depression and anxiety in a community sample with epilepsy in Brazil. Arq. Neuro-Psiquiatr. [Internet]. 2011] ; 69( 2b ): 342-348.
8. Gallucci Neto José, Marchetti Renato Luiz. Aspectos epidemiológicos e relevância dos transtornos mentais associados à epilepsia. Rev. Bras. Psiquiatr. [Internet]. 2005 Dec ; 27( 4 ): 323-328.
9. Botega, Neury José; Pondé, Milena Pereira; Medeiros, Pledson; Lima, Manuela Garcia; Guerreiro, Carlos Alberto Mantovani. Validação da escala hospitalar de ansiedade e depressão (HAD) em pacientes epiléticos ambulatóriais / Validation of hospital scale of anxiety and depression (HAD) in epileptic ambulatory patients. J. bras. psiquiatr;47(6):285-289, jun. 1998
10. Álvarez Pérez P., Rubio Nazábal E., Marey López J.. Hipersensibilidad a fármacos antiepilépticos. Medifam. 2002 Jun; 12( 6 ): 76-81.
11. Carrizosa Moog Jaime. Efectos cognitivos de los medicamentos antiepilépticos. Iatreia. 2009 Dic ; 22( 4 ): 350-358.
12. Atlas Epilepsy Care in the World. World Health Organization. 2005- Geneva. Disponible en: http://apps.who.int/iris/bitstream/handle/
13. Epilepsy. Capitulo 11. Neuroepidemiology in Tropical Health. 2018, Pages 145-154
14. Rondón, Juana; Betancourt, Xiomara; Conteras, Alba. Prevalencia real de epilepsia en un programa de salud mental. Merida-Venezuela.
15. Rev. salud pública;10(4):643-649, sept.-oct. 2008
16. Assis, Telma M. R; Bacellar, Aroldo; Costa, Gersonita; Nascimento, Osvaldo J. M. Preditores de mortalidade de epilepsia e crises epilépticas entre idosos hospitalizados. Arq. neuropsiquiatr;73(6):510-515, 06/2015.
17. Castaño Catrillón, José Jaime y Muñoz Cuervo, Alberto. Factores de riesgo presentes en una muestra de población epiléptica de Manizales, Caldas, Colombia. Arch. med;8(1):32-39, jun. 2008.
18. Carrizosa, Jaime. Prevalencia, incidencia y brecha terapéutica en la epilepsia. Iatreia;20(3):282-296, sept. 2007.
19. Durón, Reyna; Medina, Marco Tulio; Holden, Kenton; Ramírez, Francisco; Aguilar, Rafael; Zelaya, Amilcar; Rivera, Marisabel; Pavón, Lorenzo. Estudio sobre el cumplimiento del tratamiento por los pacientes epilépticos en el Hospital Escuela. Rev. méd. hondur;69(4):140-146, oct.-dic. 2001.
20. Carrizosa, Jaime; Mesa, Doris Lucia; Reyes, Hna. Elvira. Epilepsy comprehensive program in Puerto Berrio, Antioquia (Colombia) Acta neurol. colomb;16(1):25-27, jan. 2000
21. Berg AT; Altalib HH; Devinsky O. Ann & Robert H Lurie Children’s Hospital of Chicago, Northwestern-Feinberg School of Medicine, Chicago, Illinois, U.S.A. Psychiatric and behavioral comorbidities in epilepsy: A critical reappraisal. Epilepsia;58(7):1123-1130, 2017.
22. Thurman DJ, Beghi E, Begley CE, Berg AT, Buchhalter JR, Ding D, Hesdorffer DC, Hauser WA, Kazis L, Kobau R, Kroner B, Labiner D, Liow K, Logroscino G, Medina MT, Newton CR, Parko K , Pascual A, Preux PM, Sander JW, Selassie A, Theodore W, Tomson T, Wiebe S; Comisión de Epidemiología de ILAE. Estándares para estudios epidemiológicos y vigilancia de la epilepsia. Epilepsia, 52 Suppl 7: 2-26 2011 Sep.
